Altrinsic Global Advisors LLC Delcath Systems, Inc. Transaction History

Altrinsic Global Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.64 - $7.95 $507,600 - $715,500	-90,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.2 - $11.72 $72,000 - $117,200	10,000 Added 12.5%	90,000 $698,000
Q2 2021 Aug 13, 2021	BUY	$9.54 - $15.1 $286,200 - $453,000	30,000 Added 60.0%	80,000 $1.01 Million
Q4 2020 Feb 16, 2021	BUY	$10.55 - $18.69 $527,500 - $934,500	50,000 New	50,000 $896,000

7.52M

198K

41.7K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $138M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.